Alnylam Pharmaceuticals
ALNY
#582
Rank
S$47.46 B
Marketcap
$367.98
Share price
1.91%
Change (1 day)
64.39%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: S$47.46 Billion

As of November 2024 Alnylam Pharmaceuticals has a market cap of S$47.46 Billion. This makes Alnylam Pharmaceuticals the world's 582th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024S$47.46 B49.61%
2023S$31.72 B-19.06%
2022S$39.19 B42.95%
2021S$27.41 B37.26%
2020S$19.97 B14.68%
2019S$17.41 B72.85%
2018S$10.07 B-40.2%
2017S$16.85 B262.41%
2016S$4.64 B-58.96%
2015S$11.33 B14.51%
2014S$9.89 B90.55%
2013S$5.19 B343.28%
2012S$1.17 B159.77%
2011S$0.45 B-16.15%
2010S$0.53 B-48.03%
2009S$1.03 B-29.34%
2008S$1.46 B-14.16%
2007S$1.70 B40.33%
2006S$1.21 B183.44%
2005S$0.42 B82.53%
2004S$0.23 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

S$47.46 Billion
by Yahoo Finance info icon info icon
S$47.46 Billion
by CompaniesMarketCap info icon info icon
S$47.46 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
S$3.60 B-92.40%๐Ÿ‡บ๐Ÿ‡ธ USA
S$120.74 B 154.41%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.40 B-67.54%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.39 B-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.12 B-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
S$282.28 B 494.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$172.46 B 263.38%๐Ÿ‡ซ๐Ÿ‡ท France
S$25.71 B-45.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel